Humana to sell interest in Kindred subsidary to Clayton, Dubilier & Rice
Press releases | April 21, 2022
Fried Frank advised Humana, Inc. ("Humana"), in its US$3.4 billion definitive agreement to divest a majority interest in the Hospice and Personal Care divisions of Humana's Kindred at Home subsidiary to Clayton, Dubilier & Rice. These divisions include patient-centered services for hospice, palliative, community and personal care. Humana is an American health insurance company. Clayton, Dubilier & Rice is a private investment firm. The transaction is expected to close in the third quarter of 2022.
The Fried Frank team was led by corporate partner Brian T. Mangino and included corporate partners Andrea Gede-Lange, Stewart A. Kagan and Joshua Wechsler; antitrust and competition partner Nathaniel L. Asker; executive compensation & ERISA partner Jason R. Ertel; intellectual property and technology partner Jason L. Greenberg; tax partners Shane C. Hoffmann and Alan S. Kaden; corporate special counsel Alex J. Speyer; corporate associates Ronald V. Distante, Whitney J. Dumeng, Yvonne Ho, Chelsea C. Lomprey, Alison McCormick, Randa J. Medley, Jeremy Merkin and Cassidy Schuma; and corporate law clerks Rachel Chernov, Noelle Graham, Mark McCormack and Jaklin Guyumjyan.
This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.